OBI Pharma, Inc. to Present at the J.P. Morgan Healthcare Conference

SAN FRANCISCO, Jan. 9, 2020 — OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), announced that Michael Chang, Ph.D. Chairman and CEO, will present a company overview at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2019 at 4:30 p.m. PST/ 7:30 p.m EST, in San Francisco, CA. About OBI Pharma, Inc. OBI Pharma has a diverse portfolio of innovative cancer therapies […]

This article is password protected.

To view the content, please enter your password in the field below